KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma (original) (raw)

• Hezel, A. F., Kimmelman, A. C., Stanger, B. Z., Bardeesy, N. & Depinho, R. A. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev. 20, 1218–1249 (2006).
  Article CAS PubMed Google Scholar
• Corcoran, R. B. & Scott, M. P. A mouse model for medulloblastoma and basal cell nevus syndrome. J. Neurooncol. 53, 307–318 (2001).
  Article CAS PubMed Google Scholar
• Romer, J. T. et al. Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1 +/− p53 −/− mice. Cancer Cell 6, 229–240 (2004).
  Article CAS PubMed Google Scholar
• Taketo, M. M. & Edelmann, W. Mouse models of colon cancer. Gastroenterology 136, 780–798 (2009).
  Article CAS PubMed Google Scholar
• Habbe, N., Langer, P., Sina-Frey, M. & Bartsch, D. K. Familial pancreatic cancer syndromes. Endocrinol. Metab. Clin. North Am. 35, 417–430 (2006).
  Article CAS PubMed Google Scholar
• Wescott, M. P. & Rustgi, A. K. Pancreatic cancer: translating lessons from mouse models and hereditary syndromes. Cancer Prev. Res. 1, 503–506 (2008).
  Article CAS Google Scholar
• Almoguera, C. et al. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53, 549–554 (1988).
  Article CAS PubMed Google Scholar
• Caldas, C. et al. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nature Genet. 8, 27–32 (1994).
  Article CAS PubMed Google Scholar
• Ruggeri, B. et al. Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-1 tumor-suppressor genes. Oncogene 7, 1503–1511 (1992).
  CAS PubMed Google Scholar
• Scarpa, A. et al. Pancreatic adenocarcinomas frequently show p53 gene mutations. Am. J. Pathol. 142, 1534–1543 (1993).
  CAS PubMed PubMed Central Google Scholar
• Hahn, S. A. et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271, 350–353 (1996).
  Article CAS PubMed Google Scholar
• Rodriguez-Viciana, P. et al. Cancer targets in the Ras pathway. Cold Spring Harb. Symp. Quant. Biol. 70, 461–467 (2005).
  Article CAS PubMed Google Scholar
• Jones, S. et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321, 1801–1806 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Hruban, R. H., Maitra, A., Kern, S. E. & Goggins, M. Precursors to pancreatic cancer. Gastroenterol. Clin. North Am. 36, 831–849, vi (2007).
  Article PubMed PubMed Central Google Scholar
• Hruban, R. H. et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am. J. Surg. Pathol. 28, 977–987 (2004).
  Article PubMed Google Scholar
• Feldmann, G., Beaty, R., Hruban, R. H. & Maitra, A. Molecular genetics of pancreatic intraepithelial neoplasia. J. Hepatobiliary Pancreat. Surg. 14, 224–232 (2007).
  Article PubMed PubMed Central Google Scholar
• Lohr, M., Kloppel, G., Maisonneuve, P., Lowenfels, A. B. & Luttges, J. Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis. Neoplasia 7, 17–23 (2005).
  Article PubMed PubMed Central CAS Google Scholar
• Maitra, A. et al. Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray. Mod. Pathol. 16, 902–912 (2003).
  Article PubMed Google Scholar
• Wilentz, R. E. et al. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res. 60, 2002–2006 (2000).
  CAS PubMed Google Scholar
• Grippo, P. J., Nowlin, P. S., Demeure, M. J., Longnecker, D. S. & Sandgren, E. P. Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice. Cancer Res. 63, 2016–2019 (2003).
  CAS PubMed Google Scholar
• Brembeck, F. H. et al. The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice. Cancer Res. 63, 2005–2009 (2003).
  CAS PubMed Google Scholar
• Tuveson, D. A. et al. Endogenous oncogenic K-ras G12D stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell 5, 375–387 (2004).
  Article CAS PubMed Google Scholar
• Hingorani, S. R. et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4, 437–450 (2003). The first example of a conditional Kras - driven PDAC mouse model that recapitulates the progression observed in humans.
  Article CAS PubMed Google Scholar
• Guerra, C. et al. Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer Cell 11, 291–302 (2007). The first direct functional demonstration that PDAC can arise from non-ductal cells. This paper also established a functional link between pancreatitis and PDAC initiation and progression.
  Article CAS PubMed Google Scholar
• Habbe, N. et al. Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice. Proc. Natl Acad. Sci. USA 105, 18913–18918 (2008). This study provided evidence that mutant Kras is sufficient to reprogram acini into the PanIN lineage in the absence of tissue damage.
  Article CAS PubMed PubMed Central Google Scholar
• De La O, J. et al. Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia. Proc. Natl Acad. Sci. USA 105, 18907–18912 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Shi, G. et al. Loss of the acinar-restricted transcription factor Mist1 accelerates Kras-induced pancreatic intraepithelial neoplasia. Gastroenterology 136, 1368–1378 (2009).
  Article CAS PubMed Google Scholar
• Ji, B. et al. Ras activity levels control the development of pancreatic diseases. Gastroenterology 137, 1072–1082, e6 (2009).
  Article CAS PubMed Google Scholar
• Morris, J. P. 4th, Cano, D. A., Sekine, S., Wang, S. C. & Hebrok, M. β-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice. J. Clin. Invest. 120, 508–520 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Gidekel Friedlander, S. Y. et al. Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras. Cancer Cell 16, 379–389 (2009). This study provided evidence that mutant Kras combined with chronic pancreatitis can drive endocrine cells into the PanIN–PDAC lineage.
  Article PubMed PubMed Central CAS Google Scholar
• Aguirre, A. J. et al. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes Dev. 17, 3112–3126 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Bardeesy, N. et al. Both p16Ink4a and the p19Arf–p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse. Proc. Natl Acad. Sci. USA 103, 5947–5952 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Hingorani, S. R. et al. Trp53 R172H and Kras G12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7, 469–483 (2005). Mutant p53 drives both PDAC progression and the development of metastasis and genomic instability, which are hallmarks of the human disease.
  Article CAS PubMed Google Scholar
• Bardeesy, N. et al. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes Dev. 20, 3130–3146 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Ijichi, H. et al. Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-β signaling in cooperation with active Kras expression. Genes Dev. 20, 3147–3160 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Izeradjene, K. et al. KrasG12D and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas. Cancer Cell 11, 229–243 (2007).
  Article CAS PubMed Google Scholar
• Kojima, K. et al. Inactivation of Smad4 accelerates KrasG12D-mediated pancreatic neoplasia. Cancer Res. 67, 8121–8130 (2007).
  Article CAS PubMed Google Scholar
• Vincent, D. F. et al. Inactivation of TIF1γ cooperates with Kras to induce cystic tumors of the pancreas. PLoS Genet. 5, e1000575 (2009).
  Article PubMed PubMed Central CAS Google Scholar
• Quint, E. et al. Bone patterning is altered in the regenerating zebrafish caudal fin after ectopic expression of sonic hedgehog and bmp2b or exposure to cyclopamine. Proc. Natl Acad. Sci. USA 99, 8713–8718 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Karhadkar, S. S. et al. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 431, 707–712 (2004).
  Article CAS PubMed Google Scholar
• Stecca, B. & Ruiz i Altaba, A. Brain as a paradigm of organ growth: Hedgehog–Gli signaling in neural stem cells and brain tumors. J. Neurobiol. 64, 476–490 (2005).
  Article CAS PubMed Google Scholar
• Liu, S. et al. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res. 66, 6063–6071 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Li, N. et al. Reciprocal intraepithelial interactions between TP63 and hedgehog signaling regulate quiescence and activation of progenitor elaboration by mammary stem cells. Stem Cells 26, 1253–1264 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Hooper, J. E. & Scott, M. P. Communicating with Hedgehogs. Nature Rev. Mol. Cell Biol. 6, 306–317 (2005).
  Article CAS Google Scholar
• Jiang, J. & Hui, C. C. Hedgehog signaling in development and cancer. Dev. Cell 15, 801–812 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Pan, Y., Bai, C. B., Joyner, A. L. & Wang, B. Sonic hedgehog signaling regulates Gli2 transcriptional activity by suppressing its processing and degradation. Mol. Cell. Biol. 26, 3365–3377 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, B., Fallon, J. F. & Beachy, P. A. Hedgehog-regulated processing of Gli3 produces an anterior/posterior repressor gradient in the developing vertebrate limb. Cell 100, 423–434 (2000).
  Article CAS PubMed Google Scholar
• Kenney, A. M. & Rowitch, D. H. Sonic hedgehog promotes G1 cyclin expression and sustained cell cycle progression in mammalian neuronal precursors. Mol. Cell. Biol. 20, 9055–9067 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Mill, P. et al. Shh controls epithelial proliferation via independent pathways that converge on N-Myc. Dev. Cell 9, 293–303 (2005).
  Article CAS PubMed Google Scholar
• Regl, G. et al. Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2. Cancer Res. 64, 7724–7731 (2004).
  Article CAS PubMed Google Scholar
• Teh, M. T. et al. FOXM1 is a downstream target of Gli1 in basal cell carcinomas. Cancer Res. 62, 4773–4780 (2002).
  CAS PubMed Google Scholar
• Brancaccio, A. et al. Requirement of the forkhead gene Foxe1, a target of sonic hedgehog signaling, in hair follicle morphogenesis. Hum. Mol. Genet. 13, 2595–2606 (2004).
  Article CAS PubMed Google Scholar
• Rubin, L. L. & de Sauvage, F. J. Targeting the Hedgehog pathway in cancer. Nature Rev. Drug Discov. 5, 1026–1033 (2006).
  Article CAS Google Scholar
• Hahn, H. et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85, 841–851 (1996).
  Article CAS PubMed Google Scholar
• Xie, J. et al. Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature 391, 90–92 (1998).
  Article CAS PubMed Google Scholar
• Raffel, C. et al. Sporadic medulloblastomas contain PTCH mutations. Cancer Res. 57, 842–845 (1997).
  CAS PubMed Google Scholar
• Thayer, S. P. et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425, 851–856 (2003). Hh ligands are frequently overexpressed in human PDAC, and enforced Hh ligand expression during pancreatic development can lead to elements of PDAC initiation.
  Article CAS PubMed PubMed Central Google Scholar
• Feldmann, G. et al. An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer. Mol. Cancer Ther. 7, 2725–2735 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Feldmann, G. et al. Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer. Gut 57, 1420–1430 (2008).
  Article CAS PubMed Google Scholar
• Feldmann, G. et al. Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. Cancer Res. 67, 2187–2196 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Olive, K. P. et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 324, 1457–1461 (2009). SMO inhibition increases accessibility of chemotherapeutic agents and decreases the fibroblast compartment in a mouse model of PDAC.
  Article CAS PubMed PubMed Central Google Scholar
• Yauch, R. L. et al. A paracrine requirement for hedgehog signalling in cancer. Nature 455, 406–410 (2008). PDAC cells do not respond to Hh ligand or SMO inhibition. This study provides evidence that Hh ligand activates the signalling cascade in cells in the tumour microenvironment, providing paracrine tumour support.
  Article CAS PubMed Google Scholar
• Tian, H. et al. Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesis. Proc. Natl Acad. Sci. USA 106, 4254–4259 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Kalluri, R. & Zeisberg, M. Fibroblasts in cancer. Nature Rev. Cancer 6, 392–401 (2006).
  Article CAS Google Scholar
• Olumi, A. F. et al. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 59, 5002–5011 (1999).
  CAS PubMed Google Scholar
• Orimo, A. et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335–348 (2005).
  Article CAS PubMed Google Scholar
• Bachem, M. G. et al. Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells. Gastroenterology 128, 907–921 (2005).
  Article CAS PubMed Google Scholar
• Hwang, R. F. et al. Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res. 68, 918–926 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Vonlaufen, A. et al. Pancreatic stellate cells: partners in crime with pancreatic cancer cells. Cancer Res. 68, 2085–2093 (2008).
  Article CAS PubMed Google Scholar
• Bailey, J. M., Mohr, A. M. & Hollingsworth, M. A. Sonic hedgehog paracrine signaling regulates metastasis and lymphangiogenesis in pancreatic cancer. Oncogene 28, 3513–3525 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Bailey, J. M. et al. Sonic hedgehog promotes desmoplasia in pancreatic cancer. Clin. Cancer Res. 14, 5995–6004 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Menke, A. et al. Down-regulation of E-cadherin gene expression by collagen type I and type III in pancreatic cancer cell lines. Cancer Res. 61, 3508–3517 (2001).
  CAS PubMed Google Scholar
• Armstrong, T. et al. Type I collagen promotes the malignant phenotype of pancreatic ductal adenocarcinoma. Clin. Cancer Res. 10, 7427–7437 (2004).
  Article CAS PubMed Google Scholar
• Shintani, Y., Hollingsworth, M. A., Wheelock, M. J. & Johnson, K. R. Collagen I promotes metastasis in pancreatic cancer by activating c-Jun NH2-terminal kinase 1 and up-regulating N-cadherin expression. Cancer Res. 66, 11745–11753 (2006).
  Article CAS PubMed Google Scholar
• Koenig, A., Mueller, C., Hasel, C., Adler, G. & Menke, A. Collagen type I induces disruption of E-cadherin-mediated cell–cell contacts and promotes proliferation of pancreatic carcinoma cells. Cancer Res. 66, 4662–4671 (2006).
  Article CAS PubMed Google Scholar
• Nakamura, K. et al. Hedgehog promotes neovascularization in pancreatic cancers by regulating Ang-1 and IGF-1 expression in bone-marrow derived pro-angiogenic cells. PLoS ONE 5, e8824 (2010).
  Article PubMed PubMed Central CAS Google Scholar
• Burris, H. A. . et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J. Clin. Oncol. 15, 2403–2413 (1997).
  Article CAS PubMed Google Scholar
• Tempero, M. et al. Randomized Phase II comparison of dose-intense gemcitabine: thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma. J. Clin. Oncol. 21, 3402–3408 (2003).
  Article CAS PubMed Google Scholar
• Tsuda, N. et al. Synthetic microRNA designed to target glioma-associated antigen 1 transcription factor inhibits division and induces late apoptosis in pancreatic tumor cells. Clin. Cancer Res. 12, 6557–6564 (2006).
  Article CAS PubMed Google Scholar
• Lauth, M., Bergstrom, A., Shimokawa, T. & Toftgard, R. Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists. Proc. Natl Acad. Sci. USA 104, 8455–8460 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Nolan-Stevaux, O. et al. GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation. Genes Dev. 23, 24–36 (2009). KRAS-driven PDAC develops in the absence of smoothened expression. However, aberrant Hh ligand expression and epithelial Gli signalling remain present, suggesting that they are uncoupled during PDAC development.
  Article CAS PubMed PubMed Central Google Scholar
• Ji, Z., Mei, F. C., Xie, J. & Cheng, X. Oncogenic KRAS activates Hedgehog signaling pathway in pancreatic cancer cells. J. Biol. Chem. 282, 14048–14055 (2007).
  Article CAS PubMed Google Scholar
• Dennler, S. et al. Induction of sonic hedgehog mediators by transforming growth factor-β: Smad3-dependent activation of Gli2 and Gli1 expression in vitro and in vivo. Cancer Res. 67, 6981–6986 (2007).
  Article CAS PubMed Google Scholar
• Apelqvist, A., Ahlgren, U. & Edlund, H. Sonic hedgehog directs specialised mesoderm differentiation in the intestine and pancreas. Curr. Biol. 7, 801–804 (1997).
  Article CAS PubMed Google Scholar
• Pasca di Magliano, M. et al. Hedgehog/Ras interactions regulate early stages of pancreatic cancer. Genes Dev. 20, 3161–3173 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Clevers, H. Wnt/β-catenin signaling in development and disease. Cell 127, 469–480 (2006).
  Article CAS PubMed Google Scholar
• MacDonald, B. T., Tamai, K. & He, X. Wnt/β-catenin signaling: components, mechanisms, and diseases. Dev. Cell 17, 9–26 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Schwartz, A. L. et al. Phenylmethimazole decreases Toll-like receptor 3 and noncanonical Wnt5a expression in pancreatic cancer and melanoma together with tumor cell growth and migration. Clin. Cancer Res. 15, 4114–4122 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Pilarsky, C. et al. Activation of Wnt signalling in stroma from pancreatic cancer identified by gene expression profiling. J. Cell. Mol. Med. 12, 2823–2835 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Segditsas, S. & Tomlinson, I. Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene 25, 7531–7537 (2006).
  Article CAS PubMed Google Scholar
• Seymour, A. B. et al. Allelotype of pancreatic adenocarcinoma. Cancer Res. 54, 2761–2764 (1994).
  CAS PubMed Google Scholar
• Gerdes, B. et al. Analysis of β-catenin gene mutations in pancreatic tumors. Digestion 60, 544–548 (1999).
  Article CAS PubMed Google Scholar
• Abraham, S. C. et al. Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor β-catenin mutations. Am. J. Pathol. 160, 1361–1369 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Al-Aynati, M. M., Radulovich, N., Riddell, R. H. & Tsao, M. S. Epithelial-cadherin and β-catenin expression changes in pancreatic intraepithelial neoplasia. Clin. Cancer Res. 10, 1235–1240 (2004).
  Article CAS PubMed Google Scholar
• Zeng, G. et al. Aberrant Wnt/β-catenin signaling in pancreatic adenocarcinoma. Neoplasia 8, 279–289 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Pasca di Magliano, M. et al. Common activation of canonical Wnt signaling in pancreatic adenocarcinoma. PLoS ONE 2, e1155 (2007).
  Article PubMed PubMed Central CAS Google Scholar
• Wang, L. et al. Oncogenic function of ATDC in pancreatic cancer through Wnt pathway activation and β-catenin stabilization. Cancer Cell 15, 207–219 (2009). Cell autonomous ATDC supports β-catenin accumulation and signalling during PDAC development and impacts tumour cell proliferation and transformed characteristics.
  Article CAS PubMed PubMed Central Google Scholar
• Froeling, F. E. et al. Organotypic culture model of pancreatic cancer demonstrates that stromal cells modulate E-cadherin, β-catenin, and Ezrin expression in tumor cells. Am. J. Pathol. 175, 636–648 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Nawroth, R. et al. Extracellular sulfatases, elements of the Wnt signaling pathway, positively regulate growth and tumorigenicity of human pancreatic cancer cells. PLoS ONE 2, e392 (2007).
  Article PubMed PubMed Central CAS Google Scholar
• Takahashi, N. et al. Dickkopf-1 is overexpressed in human pancreatic ductal adenocarcinoma cells and is involved in invasive growth. Int. J. Cancer 126, 1611–1620 (2009).
  Google Scholar
• Kemler, R. et al. Stabilization of β-catenin in the mouse zygote leads to premature epithelial–mesenchymal transition in the epiblast. Development 131, 5817–5824 (2004).
  Article CAS PubMed Google Scholar
• Heiser, P. W., Lau, J., Taketo, M. M., Herrera, P. L. & Hebrok, M. Stabilization of β-catenin impacts pancreas growth. Development 133, 2023–2032 (2006).
  Article CAS PubMed Google Scholar
• Strom, A. et al. Unique mechanisms of growth regulation and tumor suppression upon Apc inactivation in the pancreas. Development 134, 2719–2725 (2007).
  Article CAS PubMed Google Scholar
• Heiser, P. W. et al. Stabilization of β-catenin induces pancreas tumor formation. Gastroenterology 135, 1288–1300 (2008).
  Article CAS PubMed Google Scholar
• Nishimori, I. et al. Non-cystic solid-pseudopapillary tumor of the pancreas showing nuclear accumulation and activating gene mutation of β-catenin. Pathol. Int. 56, 707–711 (2006).
  Article CAS PubMed Google Scholar
• Janssen, K. P. et al. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression. Gastroenterology 131, 1096–1109 (2006).
  Article CAS PubMed Google Scholar
• Phelps, R. A. et al. A two-step model for colon adenoma initiation and progression caused by APC loss. Cell 137, 623–634 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Sansom, O. J. et al. Loss of Apc allows phenotypic manifestation of the transforming properties of an endogenous K-ras oncogene in vivo. Proc. Natl Acad. Sci. USA 103, 14122–14127 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Lowenfels, A. B. et al. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N. Engl. J. Med. 328, 1433–1437 (1993).
  Article CAS PubMed Google Scholar
• Malka, D. et al. Risk of pancreatic adenocarcinoma in chronic pancreatitis. Gut 51, 849–852 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Hassan, M. M. et al. Risk factors for pancreatic cancer: case–control study. Am. J. Gastroenterol. 102, 2696–2707 (2007).
  Article PubMed PubMed Central Google Scholar
• Fendrich, V. et al. Hedgehog signaling is required for effective regeneration of exocrine pancreas. Gastroenterology 135, 621–631 (2008). This study demonstrated that acinar cells regenerate from pre-existing acinar cells through ductal intermediates following chemically induced pancreatitis.
  Article CAS PubMed Google Scholar
• Jensen, J. N. et al. Recapitulation of elements of embryonic development in adult mouse pancreatic regeneration. Gastroenterology 128, 728–741 (2005). This study provided evidence that embryonic signalling pathways are reactivated during acinar regeneration following chemically induced pancreatitis.
  Article CAS PubMed Google Scholar
• Desai, B. M. et al. Preexisting pancreatic acinar cells contribute to acinar cell, but not islet β cell, regeneration. J. Clin. Invest. 117, 971–977 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Zhu, L., Shi, G., Schmidt, C. M., Hruban, R. H. & Konieczny, S. F. Acinar cells contribute to the molecular heterogeneity of pancreatic intraepithelial neoplasia. Am. J. Pathol. 171, 263–273 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Siveke, J. T. et al. Concomitant pancreatic activation of Kras G12D and Tgfa results in cystic papillary neoplasms reminiscent of human IPMN. Cancer Cell 12, 266–279 (2007).
  Article CAS PubMed Google Scholar
• Elghazi, L. et al. Regulation of pancreas plasticity and malignant transformation by Akt signaling. Gastroenterology 136, 1091–1103 (2009).
  Article CAS PubMed Google Scholar
• Carriere, C., Young, A. L., Gunn, J. R., Longnecker, D. S. & Korc, M. Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic Kras. Biochem. Biophys. Res. Commun. 382, 561–565 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Siveke, J. T. et al. Notch signaling is required for exocrine regeneration after acute pancreatitis. Gastroenterology 134, 544–555 (2008).
  Article CAS PubMed Google Scholar
• Strobel, O. et al. In vivo lineage tracing defines the role of acinar-to-ductal transdifferentiation in inflammatory ductal metaplasia. Gastroenterology 133, 1999–2009 (2007).
  Article PubMed Google Scholar
• Strobel, O. et al. Pancreatic duct glands are distinct ductal compartments that react to chronic injury and mediate Shh-induced metaplasia. Gastroenterology 138, 1166–1177.
  Article PubMed Google Scholar
• Means, A. L. et al. Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates. Development 132, 3767–3776 (2005).
  Article CAS PubMed Google Scholar
• Miyamoto, Y. et al. Notch mediates TGF α-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell 3, 565–576 (2003).
  Article CAS PubMed Google Scholar
• Sawey, E. T., Johnson, J. A. & Crawford, H. C. Matrix metalloproteinase 7 controls pancreatic acinar cell transdifferentiation by activating the Notch signaling pathway. Proc. Natl Acad. Sci. USA 104, 19327–19332 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Miyatsuka, T. et al. Persistent expression of PDX-1 in the pancreas causes acinar-to-ductal metaplasia through Stat3 activation. Genes Dev. 20, 1435–1440 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Zhu, L. et al. Inhibition of Mist1 homodimer formation induces pancreatic acinar-to-ductal metaplasia. Mol. Cell. Biol. 24, 2673–2681 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Hanlon, L. et al. Notch1 functions as a tumor suppressor in a model of K-ras-induced pancreatic ductal adenocarcinoma. Cancer Res. 70, 4280–4286 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Hruban, R. H., Goggins, M., Parsons, J. & Kern, S. E. Progression model for pancreatic cancer. Clin. Cancer Res. 6, 2969–2972 (2000).
  CAS PubMed Google Scholar
• Carrière, C., Seeley, E. S., Goetze, T., Longnecker, D. S. & Korc, M. The Nestin progenitor lineage is the compartment of origin for pancreatic intraepithelial neoplasia. Proc. Natl Acad. Sci. USA 104, 4437–4442 (2007).
  Article PubMed PubMed Central CAS Google Scholar
• Mao, J. et al. A novel somatic mouse model to survey tumorigenic potential applied to the Hedgehog pathway. Cancer Res. 66, 10171–10178 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Romero, D., Iglesias, M., Vary, C. P. & Quintanilla, M. Functional blockade of Smad4 leads to a decrease in β-catenin levels and signaling activity in human pancreatic carcinoma cells. Carcinogenesis 29, 1070–1076 (2008).
  Article CAS PubMed Google Scholar